Cambium Bio Limited
CMB
Kedudukan dalam Saham
#32452
Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on... Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Harga Saham
$0.31613178
Disegerakkan terakhir: 2026-10-21
Modal Pasaran
$9.30M
Perubahan (1 hari)
-0.39%
Perubahan (1 tahun)
5,893.70%
Negara
AU
Perdagangan Cambium Bio Limited (CMB)
Kategori
Healthcare
Sejarah harga saham bagi Cambium Bio Limited (CMB)
Harga penutupan tertinggi: $0.01 pada 2024-05-01
Harga penutupan terendah: $0.25 pada 2013-09-01
Harga penutupan terendah: $0.25 pada 2013-09-01
Sejarah harga saham Cambium Bio Limited dari 2013 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2024 | 119.50% |
| 2023 | -92.08% |
| 2022 | -41.49% |
| 2021 | -42.78% |
| 2020 | 56.83% |
| 2019 | -53.42% |
| 2018 | 31.72% |
| 2017 | -21.51% |
| 2016 | 74.18% |
| 2015 | -41.39% |
| 2014 | -67.54% |
| 2013 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $536.13 | 25.72% |
US
|
|
| $200.12 | 645.31% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $880.01 | 8.09% |
NL
|
